Press releases
- SHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood Test
- SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones
- Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine’s SmartHeart® in Post-ACS Patient Care
- SHL Telemedicine’s SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 Experiment
- SHL Telemedicine: Invitation to Conference Call Presenting Annual Results 2023
- SHL Telemedicine Receives Buy Rating with $11.00 Price Target
More ▼
Key statistics
On Saturday, SHL Telemedicine Ltd (0QMX:LSE) closed at 0.00, -100.00% above its 52-week low of 5.10, set on Feb 09, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 5.25 |
Average volume | -- |
---|---|
Shares outstanding | 16.39m |
Free float | 8.68m |
P/E (TTM) | -- |
Market cap | 85.24m CHF |
EPS (TTM) | -0.3922 CHF |
Data delayed at least 20 minutes, as of Dec 30 1899.
More ▼